Pediatric Cardiovascular Effects of Imipramine and Desipramine
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 30 (1) , 100-103
- https://doi.org/10.1097/00004583-199101000-00015
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Double-blind Placebo Controlled Study of Desipramine in the Treatment of ADD: II. Serum Drug Levels and Cardiovascular FindingsJournal of the American Academy of Child & Adolescent Psychiatry, 1989
- Cardiovascular Effects of Desipramine in ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, 1989
- Imipramine in Prepubertal Major Depressive DisordersArchives of General Psychiatry, 1987
- Imipramine in adolescent major depression: plasma level and clinical responseActa Psychiatrica Scandinavica, 1986
- Cardiovascular effects of desipramine in children and adolescents with attention deficit disorderThe Journal of Pediatrics, 1985
- Plasma levels of imipramine and adverse effects in childrenAmerican Journal of Psychiatry, 1983
- Cardiovascular Effects of Therapeutic Doses of Tricyclic AntidepressantsArchives of General Psychiatry, 1981
- The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations.Circulation, 1979
- EKG Effects of Imipramine Treatment in ChildrenJournal of the American Academy of Child Psychiatry, 1979
- Imipramine and electrocardiographic abnormalities in hyperactive childrenAmerican Journal of Psychiatry, 1975